1.
Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of Latanoprost.
Roddy Gavin W, Viker Kimberly B, Winkler Nelson S, Bahler Cindy K, Holman Bradley H, Sheikh-Hamad David et al.
Invest Ophthalmol Vis SciMay 201713 citationsBasic Science
Latanoprost lowers eye pressure by increasing Stanniocalcin-1 (STC-1). STC-1 itself also reduces intraocular pressure, suggesting it's a key mediator and potential new glaucoma therapy.